Inventor · disambiguated record
Klaus Münter
Also filed as: MUENTER KLAUS · MUNTER KLAUS · Münter Klaus
19 granted patents·4 pending applications·364 citations·filing 1979–2019
94Inventor score
Files withBAYER HEALTHCARE AG5BAYER SCHERING PHARMA AG3Bayer Pharma AG3ABBOTT LAB2FIGUEROA PEREZ SANTIAGO2
Top patents by PatentIndex Score
23 records- 0197US7173037B2Carbamate-substituted pyrazolopyridinesBAYER HEALTHCARE AG·Filed 2003·Granted Feb 6, 2007·168 cites·13 claims
- 0289US7998988B2Biphenyl compounds useful in the treatment or prevention of cardiovascular disordersBAYER SCHERING PHARMA AG·Filed 2006·Granted Aug 16, 2011·15 cites·8 claims
- 0387US8436180B2Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereofBAERFACKER LARS·Filed 2008·Granted May 7, 2013·17 cites·10 claims
- 0487US7135474B2Derivatives of 2-(1-benzyl-1H-pyrazolo(3,4-B)pyridine-3-yl)-5(-4-pyridinyl)l-4-pyrimidinamines and the use thereof as quanylate cyclase stimulatorsBAYER HEALTHCARE AG·Filed 2003·Granted Nov 14, 2006·26 cites·10 claims
- 0586US8399471B2Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the sameFIGUEROA PEREZ SANTIAGO·Filed 2007·Granted Mar 19, 2013·18 cites·6 claims
- 0685US10435403B2Positive allosteric modulators of muscarinic M2 receptorBayer Pharma AG·Filed 2016·Granted Oct 8, 2019·7 cites·8 claims
- 0778US7737153B2Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2003·Granted Jun 15, 2010·16 cites·6 claims
- 0876US9051316B2Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their useBAYER IP GMBH·Filed 2013·Granted Jun 9, 2015·3 cites·12 claims
- 0975US8987256B2Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereofHAHN MICHAEL·Filed 2009·Granted Mar 24, 2015·2 cites·10 claims
- 1074US10519154B27-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereofBayer Pharma AG·Filed 2017·Granted Dec 31, 2019·2 cites·14 claims
- 1174US6197780B1Method for combating obesityKNOLL AG·Filed 1998·Granted Mar 6, 2001·35 cites·4 claims
- 1272US8329716B2Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitorsSCHIROK HARTMUT·Filed 2005·Granted Dec 11, 2012·2 cites·8 claims
- 1372US7723347B2Substituted phenylamino-pyrimidinesBAYER SCHERING PHARMA AG·Filed 2005·Granted May 25, 2010·3 cites·9 claims
- 1465US6329384B1Endothelin antagonist and renin-angiotensin system inhibitor as a combined preparationABBOTT LAB·Filed 1998·Granted Dec 11, 2001·27 cites·4 claims
- 1563US6352992B1Endothelin antagonist and beta receptor blocking agent as combined preparationsABBOTT LAB·Filed 1998·Granted Mar 5, 2002·20 cites·4 claims
- 1653US8487111B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jul 16, 2013·0 cites·8 claims
- 1752US2006183665A1Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertensionBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 1851US2019367516A1Positive allosteric modulators of muscarinic m2 receptorBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1947US4297512AProcess for the preparation of triethylamineERDOELCHEMIE GMBH·Filed 1979·Granted Oct 27, 1981·3 cites·14 claims
- 2046US2020339567A1Substituted imidazopyridine amides and use thereofBAYER AG·Filed 2018·Application pending·0 cites
- 2144US8404709B2Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereofFIGUEROA PEREZ SANTIAGO·Filed 2007·Granted Mar 26, 2013·0 cites·5 claims
- 2243US7498460B2Isophthalic acid derivativesBAYER HEALTHCARE AG·Filed 2003·Granted Mar 3, 2009·0 cites·9 claims
- 2340US2006247244A1Quinoxalinones and their use especially in the treatment of cardiovascular diseasesBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →